Gene activity patterns may help predict survival in glioma
Original title: Combined Expression of FOXO and Tribbles Proteins Predicts Survival of Glioma Patients.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was done with stored tumor data and cells in a lab dish, not tested in people.
The short version
Researchers found a pattern of gene activity in brain tumors that lines up with how long people lived.
What was studied. Researchers studied gene activity in brain tumors using four large sets of stored tumor data from past patients. They looked at seven genes, called FOXO1, FOXO3, FOXO4, FOXO6, and TRIB1, TRIB2, TRIB3. They also tested two of these genes in glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary cells grown in a lab.
What they found. The team found a pattern made up of these FOXO and Tribbles genes that was tied to how long patients lived. The pattern held up in other, separate sets of tumor data, though the best mix of genes was not the same in each one. Grade 4 tumors had more FOXO1, TRIB1, TRIB2, and TRIB3 activity, and less FOXO3 and FOXO4, than lower grade tumors. In lab cells, FOXO1 and TRIB3 seemed to help glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary cells stay alive.
What this means, and what it doesn't
What it could mean: Someday a test like this might help doctors guess how a tumor will behave. That could help with picking treatment or watching for the tumor coming back. The authors also point to drugs being developed that act on these same genes.
What it doesn't mean: This is not a treatment, and it is not a cure. The work used stored tumor data and cells in a dish, not a trial in people. The authors say the gene pattern needs much more testing before any doctor could use it. There is no test like this available today, and nothing here changes your care right now.
Source: PubMed, October 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.